BIOLASE (BIOL) Competitors

Assure (NASDAQ:IONM) and BIOLASE (NASDAQ:BIOL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership, community ranking and risk.

Do analysts prefer IONM or BIOL?

BIOLASE has a consensus price target of $1.20, indicating a potential upside of 23,900.00%. Given BIOLASE's stronger consensus rating and higher probable upside, analysts clearly believe BIOLASE is more favorable than Assure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Assure	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
BIOLASE	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Does the media refer more to IONM or BIOL?

In the previous week, BIOLASE had 2 more articles in the media than Assure. MarketBeat recorded 2 mentions for BIOLASE and 0 mentions for Assure. BIOLASE's average media sentiment score of 0.12 beat Assure's score of 0.00 indicating that BIOLASE is being referred to more favorably in the news media.

Company	Overall Sentiment
Assure	Neutral
BIOLASE	Neutral

Which has more volatility and risk, IONM or BIOL?

Assure has a beta of 1.82, meaning that its share price is 82% more volatile than the S&P 500. Comparatively, BIOLASE has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500.

Which has higher valuation & earnings, IONM or BIOL?

BIOLASE has higher revenue and earnings than Assure.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Assure	$250K	0.63	-$26.08M	N/A	N/A
BIOLASE	$48.83M	0.00	-$20.63M	-$14.94	0.00

Is IONM or BIOL more profitable?

BIOLASE has a net margin of -41.65% compared to Assure's net margin of -25,178.32%. Assure's return on equity of 0.00% beat BIOLASE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Assure	-25,178.32%	N/A	-249.78%
BIOLASE	-41.65%	-1,782.73%	-55.31%

Do institutionals and insiders hold more shares of IONM or BIOL?

3.3% of Assure shares are held by institutional investors. Comparatively, 8.8% of BIOLASE shares are held by institutional investors. 3.8% of Assure shares are held by insiders. Comparatively, 0.3% of BIOLASE shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the MarketBeat Community prefer IONM or BIOL?

BIOLASE received 289 more outperform votes than Assure when rated by MarketBeat users. Likewise, 53.19% of users gave BIOLASE an outperform vote while only 27.27% of users gave Assure an outperform vote.

Company	Underperform	Outperform
Assure	Outperform Votes 3 27.27%	Underperform Votes 8 72.73%
BIOLASE	Outperform Votes 292 53.19%	Underperform Votes 257 46.81%

Summary

BIOLASE beats Assure on 12 of the 16 factors compared between the two stocks.